Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatitis A susceptibility screening among men who have sex with men in Rio de Janeiro
RBR-7djt4pNot yet recruiting
- Sponsor
- Fundação Oswaldo Cruz
- Start
- Dec 2019
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of Hepatitis A virus vaccine in hepatitis A (HAV), sponsored by Fundação Oswaldo Cruz. Primary endpoint: Hepatitis A susceptibility status. Planned start Dec 2019; status: not yet recruiting.
02
Drugs
Hepatitis A virus vaccine
03
Conditions
hepatitis A (HAV)
Beyond the preview
Go deeper on RBR-7djt4p.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7djt4p.